We are live on
!
Find out more
Stifel Financial Portfolio holdings
AUM
$109B
1-Year Est. Return
21.36%
This Fund
S&P 500
This Quarter
Est. Return
+11%
1 Year Est. Return
+21.36%
3 Year Est. Return
+66.37%
5 Year Est. Return
+85.41%
10 Year Est. Return
+302.98%
AUM
$79.5B
AUM Growth
+$8.33B
(+12%)
Cap. Flow
+$1.12B
Cap. Flow
% of AUM
1.4%
Top 10 Holdings %
Top 10 Hldgs %
15.61%
Holding
3,472
New
202
Increased
1,584
Reduced
1,429
Closed
162
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Norfolk Southern
NSC
|
+$183M |
| 2 |
PepsiCo
PEP
|
+$115M |
| 3 |
Walmart Inc
WMT
|
+$102M |
| 4 |
iShares 10-20 Year Treasury Bond ETF
TLH
|
+$67.4M |
| 5 |
Texas Instruments
TXN
|
+$61.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$250M |
| 2 |
Pfizer
PFE
|
+$203M |
| 3 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$110M |
| 4 |
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
|
+$40.1M |
| 5 |
First Trust Value Line Dividend Fund
FVD
|
+$36.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Industrials | 10.23% |
| 3 | Healthcare | 9.67% |
| 4 | Financials | 8.3% |
| 5 | Consumer Staples | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRTS
3201
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $63.1K | ﹤0.01% |
30,940
-38,491
| -55% | -$70.3K |
|
|
VIEW
3202
DELISTED
View, Inc. Class A Common Stock
VIEW
| $62.4K | ﹤0.01% |
+17,130
| New | +$55.2K |
|
3203
Acumen Pharmaceuticals
ABOS
$165M
| $62K | ﹤0.01% |
+16,150
| New | +$47.9K |
|
3204
Genius Sports
GENI
$2.21B
| $61.8K | ﹤0.01% |
+10,000
| New | +$53.8K |
|
|
GUT
3205
Gabelli Utility Trust
GUT
$573M
| $61.6K | ﹤0.01% |
11,670
| – | – |
|
3206
Quad
QUAD
$528M
| $61.2K | ﹤0.01% |
11,300
-1,500
| -12% | -$7.32K |
|
|
CXE
3207
DELISTED
MFS High Income Municipal Trust
CXE
| $60.8K | ﹤0.01% |
17,118
| – | – |
|
3208
Lexicon Pharmaceuticals
LXRX
$1.08B
| $60.7K | ﹤0.01% |
39,652
-42,315
| -52% | -$50.3K |
|
3209
Bionano Genomics
BNGO
$12.4M
| $59.9K | ﹤0.01% |
+528
| New | +$55.1K |
|
|
TBHC
3210
DELISTED
The Brand House Collective
TBHC
| $58.3K | ﹤0.01% |
19,295
-1,000
| -5% | -$2.19K |
|
3211
Brilliant Earth
BRLT
$16.9M
| $57.4K | ﹤0.01% |
+15,418
| New | +$44.3K |
|
|
NGD
3212
DELISTED
New Gold Inc
NGD
| $56.5K | ﹤0.01% |
38,687
-8,000
| -17% | -$10.1K |
|
3213
FTAI Infrastructure
FIP
$402M
| $54.5K | ﹤0.01% |
14,000
| – | – |
|
3214
Grab
GRAB
$15B
| $53.7K | ﹤0.01% |
15,931
+2,231
| +16% | +$7.21K |
|
3215
Hecla Mining
HL
$11.2B
| $53.6K | ﹤0.01% |
11,138
-10,402
| -48% | -$45.9K |
|
|
NNDM
3216
Nano Dimension
NNDM
$324M
| $53.2K | ﹤0.01% |
22,154
-1,100
| -5% | -$2.77K |
|
3217
CI&T Inc
CINT
$454M
| $52.8K | ﹤0.01% |
+10,043
| New | +$52.7K |
|
|
AKYA
3218
DELISTED
Akoya BioSciences
AKYA
| $52.2K | ﹤0.01% |
+10,687
| New | +$44.4K |
|
3219
Clear Channel Outdoor Holdings
CCO
$1.23B
| $51.7K | ﹤0.01% |
28,400
+9,200
| +48% | +$12.7K |
|
|
TSI
3220
TCW Strategic Income Fund
TSI
$213M
| $50.6K | ﹤0.01% |
+11,020
| New | +$51.2K |
|
3221
Senseonics Holdings Inc
SENS
$274M
| $50.2K | ﹤0.01% |
4,398
+599
| +16% | +$6.84K |
|
3222
Cytosorbents Corp
CTSO
$23.9M
| $50K | ﹤0.01% |
+45,000
| New | +$66.8K |
|
3223
Ondas Inc
ONDS
$5.08B
| $49.8K | ﹤0.01% |
32,550
-10,500
| -24% | -$9.07K |
|
3224
Gerdau
GGB
$10B
| $48.5K | ﹤0.01% |
12,000
| – | – |
|
3225
Aldeyra Therapeutics
ALDX
$96.5M
| $45.7K | ﹤0.01% |
13,026
-12,297
| -49% | -$37.9K |
|
Similar funds
VAM
Stifel Financial's Q4 2023 Portfolio in Review
As of Q4 2023, Stifel Financial held 3,472 positions worth $79.5B, up 12% from $71.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Stifel Financial's Q4 2023 filing shows 202 new, 1,584 increased, 1,429 reduced and 162 closed positions. Its largest new stake was Veralto: 219,703 shares worth $18.1M. The largest sale was Target, an estimated $250M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Industrials and Healthcare.
- Stifel Financial's largest Q4 2023 buy was Veralto: 219,703 shares worth $18.1M.
- Stifel Financial added most to Norfolk Southern in Q4 2023, an estimated $183M increase.
- Stifel Financial's biggest Q4 2023 reduction was Target, cutting an estimated $250M.
- Stifel Financial fully exited Activision Blizzard in Q4 2023, selling an estimated $15.9M.
- Stifel Financial's ten largest holdings make up 16% of its $79.5B portfolio in Q4 2023.
- Stifel Financial opened 202 new positions and closed 162 in Q4 2023.
- Stifel Financial's portfolio value rose 12% quarter-over-quarter to $79.5B.
Based on Stifel Financial's 13F filing for Q4 2023, filed 12 Feb 2024.